Insight into Functional Membrane Proteins by Solution NMR: The Human Bcl-2 Protein-A Promising Cancer Drug Target

Ameeq Ul Mushtaq1, Jörgen Ådén1, Tobias Sparrman1

  • 1Department of Chemistry, Umeå University, SE-901 87 Umeå, Sweden.

Insights

Cancer cells evade programmed cell death (apoptosis) by over-expressing the anti-apoptotic Bcl-2 protein. This study uses NMR to reveal Bcl-2

Area of Science:

  • Biochemistry
  • Structural Biology
  • Cancer Biology

Background:

  • Evasion of apoptosis is a key hallmark of cancer, often driven by overexpression of anti-apoptotic proteins like Bcl-2.
  • The precise molecular mechanisms of Bcl-2's protective function at the mitochondrial outer membrane are not fully understood due to a lack of structural data.
  • Current therapeutic strategies targeting Bcl-2-sensitive cancers are limited.

Purpose of the Study:

  • To elucidate the structural mechanisms underlying Bcl-2's anti-apoptotic function.
  • To establish an NMR-based platform for fragment-based drug discovery of Bcl-2 inhibitors.
  • To identify novel therapeutic strategies for Bcl-2-sensitive cancers.

Main Methods:

  • Solution Nuclear Magnetic Resonance (NMR) spectroscopy was employed on intact human Bcl-2 protein in a membrane-mimicking micellar environment.
  • Functional Bcl-2 constructs were utilized for structure determination and drug screening.
  • Fluorine-19 (19F) NMR was combined with a fluorinated fragment library (Bionet) for inhibitor screening.

Main Results:

  • The study successfully determined structural insights into Bcl-2 function using NMR.
  • The NMR approach served as an effective platform for fragment-based drug discovery.
  • Specific Bcl-2 binders were identified using 19F NMR and the Bionet library, validating the strategy.

Conclusions:

  • The developed NMR strategy provides crucial structural insights into Bcl-2 function.
  • This approach enables the screening of functional Bcl-2 subunits as drug targets.
  • The findings pave the way for developing novel Bcl-2-selective cancer therapeutics for currently untreatable tumors.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.5K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.3K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
8.8K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.3K
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.3K